Replies to post #15576 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

FDA proposes dedicated FoB unit (i.e. separate from Office of Generic Drugs):

https://t.co/ZAQTjHhPHm

Note inclusion of MNTA’s Bruce Leicher among the participants at the 4/21/16 meeting.